Strata Critical Medical, Inc. (SRTA) insider trading.
In Q3 2026, insiders at Strata Critical Medical, Inc. reported 26 non-derivative transactions on 17 Forms 3, 4 and 5: 0 open-market purchases and 1 sale worth $29K.
- Transactions
- 26
- Purchases (P)
- 0
- Sales (S)
- 1
- Net shares, P minus S
- -5,091
- Insiders
- 10
- Last filed
- 2026-09-25
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Heyburn William A. | Director, Officer · Co-CEO and CFO | 6 | 0 | 0 |
| Tomkiel Melissa M. | Director, Officer · Co-CEO and General Counsel | 6 | 0 | 0 |
| Cohen Amir | Officer · Chief Accounting Officer | 4 | 0 | 0 |
| Wunsch Scott M | Officer · CEO, Logistics | 3 | 0 | 0 |
| Love Reginald | Director | 2 | 0 | 1 |
| Verdetto Louis R. | Officer · CEO, Clinical Services | 1 | 0 | 0 |
| Lauck Andrew | Director | 1 | 0 | 0 |
| Wiesenthal Robert S | Director | 1 | 0 | 0 |
| Philip Edward M | Director | 1 | 0 | 0 |
| Cook William L. III | Director | 1 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-24 | Heyburn William A. | F (D) | 98,356 | $5.27 | 1,757,850 | Form 4 |
| 2026-09-24 | Heyburn William A. | A (A) | 177,858 | $0 | 1,856,206 | Form 4 |
| 2026-09-24 | Tomkiel Melissa M. | F (D) | 90,797 | $5.27 | 2,153,678 | Form 4 |
| 2026-09-24 | Tomkiel Melissa M. | A (A) | 177,858 | $0 | 2,244,475 | Form 4 |
| 2026-09-08 | Heyburn William A. | F (D) | 31,671 | $5.31 | 1,678,348 | Form 4 |
| 2026-09-08 | Tomkiel Melissa M. | F (D) | 29,730 | $5.31 | 2,066,617 | Form 4 |
| 2026-09-08 | Cohen Amir | F (D) | 4,645 | $5.31 | 177,154 | Form 4 |
| 2026-09-08 | Wunsch Scott M | F (D) | 5,711 | $5.31 | 663,043 | Form 4 |
| 2026-09-08 | Verdetto Louis R. | F (D) | 5,697 | $5.31 | 1,128,096 | Form 4 |
| 2026-08-10 | Love Reginald | S (D) | 5,091 | $5.75 | 146,481 | Form 4 |
| 2026-07-31 | Cohen Amir | F (D) | 34,015 | $5.09 | 181,799 | Form 4 |
| 2026-07-31 | Tomkiel Melissa M. | F (D) | 212,309 | $5.09 | 2,096,347 | Form 4 |
| 2026-07-31 | Heyburn William A. | F (D) | 199,209 | $5.09 | 1,710,019 | Form 4 |
| 2026-07-31 | Wunsch Scott M | F (D) | 13,992 | $5.09 | 668,754 | Form 4 |
| 2026-07-30 | Cohen Amir | A (A) | 41,786 | $0 | 188,394 | Form 4 |
| 2026-07-30 | Cohen Amir | A (A) | 27,420 | $0 | 215,814 | Form 4 |
| 2026-07-30 | Tomkiel Melissa M. | A (A) | 206,953 | $0 | 2,308,656 | Form 4 |
| 2026-07-30 | Tomkiel Melissa M. | A (A) | 208,929 | $0 | 2,101,703 | Form 4 |
| 2026-07-30 | Heyburn William A. | A (A) | 179,160 | $0 | 1,909,228 | Form 4 |
| 2026-07-30 | Heyburn William A. | A (A) | 181,071 | $0 | 1,730,068 | Form 4 |
| 2026-07-30 | Wunsch Scott M | A (A) | 57,172 | $0 | 682,746 | Form 4 |
| 2026-07-30 | Lauck Andrew | A (A) | 35,260 | $0 | 170,902 | Form 4 |
| 2026-07-30 | Wiesenthal Robert S | A (A) | 50,234 | $0 | 5,325,896 | Form 4 |
| 2026-07-30 | Philip Edward M | A (A) | 30,913 | $0 | 265,078 | Form 4 |
| 2026-07-30 | Love Reginald | A (A) | 37,675 | $0 | 151,572 | Form 4 |
| 2026-07-30 | Cook William L. III | A (A) | 44,438 | $0 | 97,671 | Form 4 |
Transaction codes in this quarter
Get SRTA insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1779128&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · SRTA company page · Strata Critical Medical, Inc. on SEC.gov
Questions
Are insiders buying or selling Strata Critical Medical, Inc. (SRTA)?
In Q3 2026, insiders at Strata Critical Medical, Inc. reported 26 non-derivative transactions on 17 Forms 3, 4 and 5: 0 open-market purchases and 1 sale worth $29K. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Strata Critical Medical, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/srta.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.